Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Ibrutinib

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCGI15126

    05/03/2016

    A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

    Treatment

    VICCPHI1528

    07/22/2015

    A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with MEDI4736, in Subjects with Relapsed or Refractory Solid Tumors


    Print this page for your doctor